Tradewinds Capital Management »

Taysha Gene Therapies shares owned by Tradewinds Capital Management

Quarter-by-quarter ownership of Taysha Gene Therapies (TSHA) shares owned by Tradewinds Capital Management from 13F filings

Historical chart of Tradewinds Capital Management investment in Taysha Gene Therapies

Tip: Access up to 7 years of quarterly data

All positions including Taysha Gene Therapies held by Tradewinds Capital Management consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Taysha Gene Therapies by Tradewinds Capital Management

Quarter filed Position value Share count Share price at filing
2025-12-31 $110 20 5.50

More positions owned by Tradewinds Capital Management

Abrdn Silver Etf Trust Physcl Silvr Shs (SIVR)
World Gold Tr Spdr Gld Minis (GLDM)
Select Sector Spdr Tr State Street Tec (XLK)
Spdr Series Trust State Street Spd (SPYG)
Spdr Index Shs Fds Portfolio Emg Mk (SPEM)
Schwab Strategic Tr Us Lrg Cap Etf (SCHX)
Ishares Msci Sth Kor Etf (EWY)
Ishares Msci Spain Etf (EWP)
Spdr Series Trust State Street Spd (SPBO)
Ishares Tr Conv Bd Etf (ICVT)
Ishares Msci Italy Etf (EWI)
Franklin Templeton Etf Tr Ftse Japan Etf (FLJP)
Microsoft Corporation (MSFT)
J P Morgan Exchange Traded F Ultra Shrt Etf (JPST)
Schwab Strategic Tr Intl Eqty Etf (SCHF)

View all positions for Tradewinds Capital Management

Top funds holding Taysha Gene Therapies

Rtw Investments
RA Capital Management
venBio Select Advisor
BlackRock
FMR
Goldman Sachs Group
Vanguard Group
Siren
Octagon Capital Advisors
Point72 Asset Management
State Street Corporation
Vestal Point Capital
Deerfield Management Company
Polar Capital Holdings
Geode Capital Management

View all funds holding Taysha Gene Therapies